Retatrutide is a newly developed drug that acts as a powerful GLP-1 receptor agonist. This breakthrough method holds significant hope for controlling type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide enhances insulin secretion and reduces glucagon release, leading to improved blood sugar control. Clinical trials have demonstra